title: White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study).
abstract: Several studies have reported that inflammatory markers are associated with atrial fibrillation (AF). The white blood cell (WBC) count is a widely available and broadly used marker of systemic inflammation. We sought to investigate the association between an increased WBC count and incident AF and whether this association is mediated by smoking, myocardial infarction, and heart failure. We examined the participants in the Framingham Heart Study original cohort. Cox proportional hazard regression analysis was used to examine the relation between the WBC count and incident AF during a 5-year follow-up period. We adjusted for standard AF risk factors, smoking, previous myocardial infarction, and interim myocardial infarction and heart failure before the incident AF. Our sample consisted of 936 participants (mean age 76 ± 6 years and 61% women). The median WBC count was 6.4 × 10(9)/L (25th to 75th percentile 5.6 × 10(9)/L to 7.8 × 10(9)/L). During a median 5-year follow-up period, 82 participants (9%) developed new-onset AF. After adjusting for standard risk factors for AF, an increased WBC count was significantly associated with incident AF, with a hazard ratio per SD (0.26 × 10(9)/L) increase of 2.22 (95% confidence interval 1.10 to 4.48; p = 0.03). We found no substantive differences adjusting for smoking, previous myocardial infarction, interim myocardial infarction, or heart failure. In conclusion, in our community-based sample, an increased WBC count was associated with incident AF during 5 years of follow-up. Our findings provide additional evidence for the relation between systemic inflammation and AF.
authors.affiliation: Cardiovascular Research Center, Massachusetts General Hospital, Boston, USA.
authors.forename: Michiel
authors.initials: M
authors.lastname: Rienstra
authors.forename: Jenny X
authors.initials: JX
authors.lastname: Sun
authors.forename: Jared W
authors.initials: JW
authors.lastname: Magnani
authors.forename: Moritz F
authors.initials: MF
authors.lastname: Sinner
authors.forename: Steven A
authors.initials: SA
authors.lastname: Lubitz
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Sullivan
authors.forename: Patrick T
authors.initials: PT
authors.lastname: Ellinor
authors.forename: Emelia J
authors.initials: EJ
authors.lastname: Benjamin
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000453:epidemiology*; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000453:epidemiology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009203:Myocardial Infarction / Q000453:epidemiology; D016016:Proportional Hazards Models; D012306:Risk; D012907:Smoking / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
references.citation: J Clin Pathol. 1996 Aug;49(8):664-6
references.pmid: 8881919
references.citation: J Am Coll Cardiol. 2007 May 8;49(18):1841-50
references.pmid: 17481443
references.citation: Circulation. 1997 Nov 18;96(10):3542-8
references.pmid: 9396453
references.citation: Am J Epidemiol. 2001 Oct 15;154(8):758-64
references.pmid: 11590089
references.citation: JAMA. 1998 May 13;279(18):1477-82
references.pmid: 9600484
references.citation: Am J Hypertens. 2004 Mar;17(3):233-9
references.pmid: 15001197
references.citation: Thromb Res. 2003;111(3):137-42
references.pmid: 14678810
references.citation: J Cardiothorac Vasc Anesth. 2009 Aug;23(4):484-7
references.pmid: 19362015
references.citation: Eur Heart J. 2005 Sep;26(17):1765-73
references.pmid: 15817606
references.citation: Ann Thorac Surg. 2006 Sep;82(3):1057-61
references.pmid: 16928536
references.citation: J Clin Epidemiol. 1990;43(2):153-7
references.pmid: 2303845
references.citation: Am J Epidemiol. 2005 Dec 1;162(11):1062-9
references.pmid: 16221804
references.citation: J Cardiothorac Vasc Anesth. 2006 Feb;20(1):51-6
references.pmid: 16458214
references.citation: J Chronic Dis. 1982;35(9):703-14
references.pmid: 7107804
references.citation: Am J Cardiol. 2003 Dec 1;92(11):1343-5
references.pmid: 14636918
references.citation: N Engl J Med. 1997 May 15;336(20):1429-34
references.pmid: 9145681
references.citation: Circulation. 1993 Jul;88(1):107-15
references.pmid: 8319323
references.citation: Circulation. 2003 Dec 16;108(24):3006-10
references.pmid: 14623805
references.citation: Eur Heart J. 2003 Jul;24(14):1365-72
references.pmid: 12871694
references.citation: Obesity (Silver Spring). 2011 Jul;19(7):1482-91
references.pmid: 21233809
references.citation: Hypertens Res. 2008 Jul;31(7):1391-7
references.pmid: 18957810
references.citation: J Cardiothorac Vasc Anesth. 2009 Feb;23(1):22-7
references.pmid: 18834823
references.citation: Circulation. 1997 Aug 19;96(4):1180-4
references.pmid: 9286947
references.citation: Arch Intern Med. 2005 Mar 14;165(5):500-8
references.pmid: 15767524
references.citation: J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9
references.pmid: 15936615
references.citation: Lancet. 2009 Feb 28;373(9665):739-45
references.pmid: 19249635
references.citation: JAMA. 1992 Mar 4;267(9):1253-6
references.pmid: 1538564
references.citation: Am J Public Health Nations Health. 1951 Mar;41(3):279-81
references.pmid: 14819398
references.citation: J Am Coll Cardiol. 2010 Sep 28;56(14):1099-109
references.pmid: 20825761
references.citation: Europace. 2009 Feb;11(2):158-63
references.pmid: 19010799
references.citation: Circulation. 1995 Oct 1;92(7):1954-68
references.pmid: 7671380